Dow Up 0.08% Nasdaq Down 0.30%

Actavis plc (ACT)

-NYSE
241.81 Up 3.88(1.63%) Sep 19, 4:07PM EDT
|After Hours : 241.79 Down 0.02 (0.01%) Sep 19, 5:00PM EDT
Prev Close:237.93
Open:239.31
Bid:233.60 x 200
Ask:241.81 x 100
1y Target Est:266.95
Beta:0.35
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:236.41 - 245.50
52wk Range:136.33 - 245.50
Volume:3,676,989
Avg Vol (3m):2,320,330
Market Cap:63.90B
P/E (ttm):N/A
EPS (ttm):-3.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ACTUp 1.63%63.90B
MYLDown 2.21%17.71B
NVSDown 0.95%227.82B
TEVADown 0.48%44.53B

Key Statistics

Forward P/E (1 yr):14.77
P/S (ttm):6.22
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :13.27
Quarterly EPS Est (Sep-14) :3.09
Mean Recommendation*:1.6
PEG Ratio (5 yr expected):0.92

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Actavis plc, an integrated specialty pharmaceutical company, is engaged in the development, manufacture, marketing, sale, and distribution of pharmaceutical products in the Americas, Europe, the Middle East, Africa, Australia, and the Asia Pacific. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback